Clinox-N Uses

Rating: 2.5 - 2 review(s)
What is the dose of your medication?
sponsored

What is Clinox-N?

Clinox-N belongs to the family of medicines called antibiotics.

Topical Clinox-N is used to help control acne. It may be used alone or with one or more other medicines that are used on the skin or taken by mouth for acne.

Topical Clinox-N may also be used for other problems as determined by your doctor.

Clinox-N is available only with your doctor's prescription.

Clinox-N indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Clinox-N (Clinox-N palmitate HCl) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.

Clinox-N is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting Clinox-N the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin).

Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection.

Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections.

Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections.

Pneumococci: Serious respiratory tract infections.

Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to Clinox-N.

In Vitro Susceptibility Testing

A standardized disk testing procedure2 is recommended for determining susceptibility of aerobic bacteria to Clinox-N. A description is contained in the Clinox-N® Susceptibility Disk (Clinox-N) insert. Using this method, the laboratory can designate isolates as resistant, intermediate, or susceptible. Tube or agar dilution methods may be used for both anaerobic and aerobic bacteria. When the directions in the Clinox-N® Susceptibility Powder insert are followed, an MIC (minimal inhibitory concentration) of 1.6 mcg/mL may be considered susceptible; MICs of 1.6 to 4.8 mcg/mL may be considered intermediate and MICs greater than 4.8 mcg/mL may be considered resistant.

Clinox-N Susceptibility Disks 2 mcg. See package insert for use.

Clinox-N Susceptibility Powder 20 mg. See package insert for use.

For anaerobic bacteria the minimal inhibitory concentration (MIC) of Clinox-N can be determined by agar dilution and broth dilution (including microdilution) techniques. If MICs are not determined routinely, the disk broth method is recommended for routine use. THE KIRBY-BAUER DISK DIFFUSION METHOD AND ITS INTERPRETIVE STANDARDS ARE NOT RECOMMENDED FOR ANAEROBES.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Clinox-N and other antibacterial drugs, Clinox-N should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

How should I use Clinox-N?

Use Clinox-N cream as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Clinox-N cream.

Uses of Clinox-N in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Use: Labeled Indications

Bone and joint infections: Treatment of bone and joint infections, including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections caused by susceptible organisms.

Gynecological infections: Treatment of gynecologic infections, including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.

Intraabdominal infections: Treatment of intraabdominal infections, including peritonitis and intraabdominal abscess caused by susceptible anaerobic organisms.

Lower respiratory tract infections: Treatment of lower respiratory tract infections, including pneumonia, empyema, and lung abscess caused by susceptible anaerobes, Streptococcus pneumoniae, other streptococci (except Enterococcus faecalis), and S. aureus.

Septicemia: Treatment of septicemia caused by S. aureus, streptococci (except E. faecalis), and susceptible anaerobes.

Skin and soft tissue infection: Treatment of skin and soft tissue infection caused by Streptococcus pyogenes, S. aureus, and susceptible anaerobes.

Off Label Uses

Anthrax

Based on the Centers for Disease Control and Prevention (CDC) expert panel meetings on prevention and treatment of anthrax in adults, Clinox-N is an effective and acceptable alternative for postexposure prophylaxis or treatment of cutaneous anthrax; it is also a first-line option, in combination with other antimicrobials, for the treatment of systemic anthrax. Alternative regimens have also been suggested for other patient populations with anthrax, including injectable drug users who develop injectional anthrax.

Streptococcal (group A) pharyngitis and chronic carriage

Based on the IDSA guidelines for the diagnosis and management of group A streptococcal pharyngitis, Clinox-N is an effective and recommended alternative agent for the treatment of streptococcal pharyngitis and an option for treatment of chronic group A streptococcal carriage.

Surgical prophylaxis

Based on the American Society of Health-System Pharmacists (ASHP) clinical practice guidelines for antimicrobial prophylaxis in surgery, Clinox-N, given as an alternative antibiotic in patients with beta-lactam allergy requiring surgical prophylaxis, is effective and recommended for a number of surgical procedures.

Toxoplasma gondii encephalitis and pneumonitis (treatment/long-term maintenance)

Based on the US Department of Health and Human Services guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents and the American Society of Transplantation Infectious Diseases Community of Practice guidelines on parasitic infections in solid organ transplantation, Clinox-N (with pyrimethamine and leucovorin) is an effective and recommended alternative regimen for the treatment and long-term maintenance therapy of Toxoplasma gondii encephalitis and pneumonitis.

Clinox-N description

sponsored

Clinox-N is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound lincomycin.

Clinox-N phosphate is a water soluble ester of Clinox-N and phosphoric acid.

Clinox-N phosphate is L-threo-α-D-galacto-Octopyranoside, methyl 7-chloro-6, 7, 8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl] amino]-1-thio-, 2-(dihydrogen phosphate), (2S-trans)-.

The molecular formula is C18H34CIN2O8PS and the molecular weight is 504.96.

Clinox-N hydrochloride is the hydrated hydrochloride salt of Clinox-N. Clinox-N hydrochloride is Methyl 7-chloro-6, 7, 8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside monohydrochloride.

Clinox-N palmitate hydrochloride is a water soluble salt of ester of Clinox-N and palmitic acid. Clinox-N palmitate hydrochloride is Methyl 7-chloro-6, 7, 8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2-palmitate monohydrochloride.

Clinox-N dosage

sponsored

Clinox-N Dosage

Generic name: Clinox-N HYDROCHLORIDE 75mg

Dosage form: capsule

See also:

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

If significant diarrhea occurs during therapy, this antibiotic should be discontinued.

Adults: Serious infections – 150 to 300 mg every 6 hours. More severe infections – 300 to 450 mg every 6 hours. Pediatric Patients: Serious infections – 8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections – 16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses.

To avoid the possibility of esophageal irritation, Clinox-N HCl Capsules should be taken with a full glass of water.

Serious infections due to anaerobic bacteria are usually treated with Clinox-N PHOSPHATE® Sterile Solution. However, in clinically appropriate circumstances, the physician may elect to initiate treatment or continue treatment with Clinox-N HCl Capsules.

In cases of β-hemolytic streptococcal infections, treatment should continue for at least 10 days.

More about Clinox-N (Clinox-N)

Consumer resources

Professional resources

Other formulations

Related treatment guides

Clinox-N interactions

See also:
What other drugs will affect Clinox-N?

With simultaneous use of Clinox-N with theophylline, aminophylline, caffeine, there is an increase in their concentration in blood plasma and thus increases the risk of toxic effects.

Erythromycin increases the concentrations of cyclosporine in the blood plasma and may increase the risk of nephrotoxicity.

Drugs that block tubular secretion prolongs T1/2 of erythromycin.

Incompatible with lincomycin, Clinox-N and chloramphenicol (antagonism).

Clinox-N reduces the bactericidal action of beta-lactam antibiotics (penicillins, cephalosporins, carbapenems).

With simultaneous use of erythromycin increases the concentration of theophylline.

At the same time receiving chemotherapy, which is carried metabolism in the liver (carbamazepine, valproic acid, hexobarbital, phenytoin, alfentanil, dizopiramid, lovastatin, bromocriptine), may increase the concentration of these drugs in plasma (an inhibitor of microsomal liver enzymes).

IV injection of erythromycin increases the effects of ethanol (accelerating gastric emptying and decrease the duration of alcohol dehydrogenase in the gastric mucosa).

Erythromycin reduces the clearance of triazolam and midazolam and therefore may increase the pharmacological effects of benzodiazepines.

At the same time taking with terfenadine or astemizole may develop arrhythmias (fibrillation and ventricular flutter, ventricular tachycardia, until death); with dihydroergotamine or non hydrated ergot alkaloids may vasoconstriction to spasm, dysesthesia.

With simultaneous application Clinox-N slows elimination (increases the effect) of methylprednisolone, felodipine and anticoagulants of cumarine series.

In a joint appointment with lovastatin increased rhabdomyolysis.

Erythromycin increases the bioavailability of digoxin.

Erythromycin reduces the effectiveness of hormonal contraceptives.

Clinox-N side effects

See also:
What are the possible side effects of Clinox-N?

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

A total of 439 subjects with mild to moderate acne vulgaris were treated once daily for 12 weeks with Clinox-N Foam.

The incidence of adverse reactions occurring in ≥1% of the subjects in clinical trials comparing Clinox-N Foam and its vehicle is presented in Table 1.

Table 1: Adverse Reactions Occurring in ≥1% of Subjects

Adverse Reactions Number (%) of Subjects
Clinox-N Foam

N = 439

Vehicle Foam

N = 154

Headache 12 (3%) 1 (1%)
Application site burning 27 (6%) 14 (9%)
Application site pruritus 5 (1%) 5 (3%)
Application site dryness 4 (1%) 5 (3%)
Application site reaction, not otherwise specified 3 (1%) 4 (3%)

In a contact sensitization study, none of the 203 subjects developed evidence of allergic contact sensitization to Clinox-N Foam.

Postmarketing Experience

The following adverse reactions have been identified during post approval use of Clinox-N Foam: application site pain, application site erythema, diarrhea, urticaria, abdominal pain, hypersensitivity, rash, abdominal discomfort, nausea, seborrhea, application site rash, dizziness, pain of skin, colitis (including pseudomembranous colitis), and hemorrhagic diarrhea. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Abdominal pain and gastrointestinal disturbances, as well as gram-negative folliculitis, have also been reported in association with the use of topical formulations of Clinox-N.

Orally and parenterally administered Clinox-N have been associated with severe colitis, which may end fatally.

Clinox-N contraindications

See also:
What is the most important information I should know about Clinox-N?

You should not use this medication if you are allergic to Clinox-N or lincomycin (Bactramycin, L-Mycin, Lincocin).

Do not take Clinox-N together with erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin, Pediazole, and others).

Before using Clinox-N, tell your doctor if you have kidney disease, liver disease, an intestinal disorder such as colitis or Crohn's disease, or a history of asthma, eczema, or allergic skin reaction.

Take this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Clinox-N will not treat a viral infection such as the common cold or flu.

Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or bloody, stop taking Clinox-N and call your doctor. Do not use anti-diarrhea medicine unless your doctor tells you to.

To be sure this medication is not causing harmful effects, your blood may need to be tested often. Your kidney or liver function may also need to be tested. Visit your doctor regularly.

If you need surgery, tell the surgeon ahead of time that you are using Clinox-N. You may need to stop using the medicine for a short time.



Active ingredient matches for Clinox-N:

Clindamycin in India.

Nicotinamide in India.


Unit description / dosage (Manufacturer)Price, USD
Clinox-N Clindamycin 1 % w/w, nicotinamide 4 % w/w. T-GEL / 15g$ 1.19
CLINOX-N topical gel 15g (Will Impex)$ 1.19

List of Clinox-N substitutes (brand and generic names):

CLINOX topical gel 1 % w/w x 10g (Will Impex)$ 0.63
Clinred 1% T-GEL / 20g (Encore)$ 1.41
CLINRED GEL 1 tube / 20 GM gel each (Encore)$ 1.41
CLINRED topical gel 1 % x 20g (Encore)$ 1.41
Clinred 1% w/w Gel (Encore)$ 1.54
Clinscar 1% w/w GEL / 10g (Intra Labs India Pvt Ltd)$ 0.71
1 % w/w x 10g (Intra Labs India Pvt Ltd)$ 0.71
Clinscar Skin 10 gm Gel (Intra Labs India Pvt Ltd)$ 0.71
CLINSCAR topical gel 1 % w/w x 15g (Intra Labs India Pvt Ltd)$ 0.95
CLINSCAR lotion 1 % w/v x 25ml (Intra Labs India Pvt Ltd)$ 1.19
CLINSCAR CAP cap 300 mg x 10's (Intra Life (Cutis))$ 3.02
Clinsof 150mg CAP / 4 (East West Pharma)$ 1.57
Clinsof 300mg CAP / 4 (East West Pharma)$ 2.22
150 mg x 4's (East West Pharma)$ 1.57
300 mg x 4's (East West Pharma)$ 2.22
Clinsof 300 mg Capsule (East West Pharma)$ 0.56
Clinsof 150 mg Capsule (East West Pharma)$ 0.39
CLINSOF cap 150 mg x 4's (East West Pharma)$ 1.57
CLINSOF cap 300 mg x 4's (East West Pharma)$ 2.22
Clinsure 300 mg Capsule (B B Remedies (P) Ltd)$ 0.40
Clinton 300mg x 2mL AMP / 1 (Sympar Lifesciences)
Clinton 600mg x 4mL AMP / 1 (Sympar Lifesciences)
Clinton 300 mg Injection (Sympar Lifesciences)$ 0.67
Clinton 600 mg Injection (Sympar Lifesciences)$ 0.67
CLINTON inj 300 mg x 2 mL x 2ml (Sympar Lifesciences)
CLINTON inj 600 mg x 4 mL x 4ml (Sympar Lifesciences)
Clintop Skin 10 gm Cream (Daffohils Pharma Pvt. Ltd.)$ 0.65
Clinvan Skin 15 gm Gel (Avancer Labs (P) Ltd)$ 1.08
CLINVIVA cap 300 mg x 10's (Ikon)$ 2.41
CLINVIVA inj 300 mg x 2 mL x 2ml (Ikon)$ 1.57
CLINVIVA inj 600 mg x 4 mL x 4ml (Ikon)$ 3.10
Clinzee 1% GEL / 20g (Santiago)
1 % x 20g (Santiago)
CLINZEE topical gel 1 % x 20g (Santiago)$ 0.92
150 mg x 8's (United Biotech)
300 mg x 8's (United Biotech)
300 mg x 1's (United Biotech)
600 mg x 1's (United Biotech)

References

  1. DailyMed. "ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "nicotinamide". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. PubChem. "clindamycin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Clinox-N are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Clinox-N. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


Consumer reported price estimates

No survey data has been collected yet


1 consumer reported time for results

To what extent do I have to use Clinox-N before I begin to see changes in my health conditions?
As part of the reports released by ndrugs.com website users, it takes 1 day and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Clinox-N. To get the time effectiveness of using Clinox-N drug by other patients, please click here.
Users%
1 day1
100.0%


2 consumers reported age

Users%
16-292
100.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 14 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved